Simergent
PrivateLast Round
Series A
Mar 29, 2024
Total Funding Raised
$14.93M
Company Overview
Simergent operates in Healthcare & Life Sciences and is based in Oklahoma City, Oklahoma. Its latest recorded funding round was a Series A round in March 2024.
Simergent is a medical technology company that develops automated peritoneal dialysis devices for home use.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Simergent Comparables
Compare Simergent with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Byonyks | 86% | |
| iRen-MEDICAL | 86% | |
| Triomed AB | 84% |
For institutional investors. Book with your work email.
Simergent Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 29, 2024 | ||||
| Seed Round | Mar 29, 2024 | ||||
| Grant | Jun 24, 2022 | ||||
| Grant | Dec 20, 2019 | ||||
| Seed | Oct 26, 2017 | ||||
Grant | Sep 20, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Simergent Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| i2E | Seed |
| Plains Ventures | Series A |
| NIH RADx | Grant, Series A |
| Plains Ventures | Series A |
| SeedStep Angels | Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors grew 311% MoM, from 382 to 1.6K.
- Mar 29, 2024
Raised $9M from MTT Ventures and Pathway Bioventures.
For institutional investors. Book with your work email.
Simergent Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Simergent's valuation, stock price, and market status.
Is Simergent a public or private company?
Simergent is a private company.
What is the current stock price of Simergent?
Simergent is a private company, so its shares have no public market price. Caplight tracks Simergent's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Simergent worth (valuation)?
Valuation information for Simergent is not publicly available.
Can I buy Simergent stock?
Simergent shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Simergent's last funding round?
Simergent's most recent funding round was Series A on March 29, 2024.
Who are the main investors in Simergent?
Key investors in Simergent include i2E, Plains Ventures, NIH RADx, Plains Ventures, SeedStep Angels.
Will Simergent IPO soon?
No public IPO plans have been announced for Simergent.
How can I track Simergent secondary market activity?
Caplight tracks bids, offers, and trades in Simergent's shares on secondary markets.